Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
A Phase 2, Double-Masked, Placebo-Controlled, Dose Range Finding Study of Danicopan (ALXN2040) in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

This is a dose finding study designed to evaluate the efficacy, safety, and pharmacokinetics of danicopan in participants with GA secondary to AMD. The study consists of a Screening Period of up

atrophy
geographic atrophy
  • 1 views
  • 15 Oct, 2022
  • 59 locations
Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy

treated with eculizumab who still experience anemia and reticulocytosis, or patients currently treated with ALXN2040 (danicopan) as monotherapy. After signing consent, participants will have periodic

complement inhibitor
vaccination
neutrophil count
anemia
ravulizumab
  • 41 views
  • 07 Oct, 2022
  • 8 locations